Home/Filings/4/0001232942-04-000002
4//SEC Filing

CAVAZZA PAOLO 4

Accession 0001232942-04-000002

CIK 0000891288other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 8:31 PM ET

Size

19.1 KB

Accession

0001232942-04-000002

Insider Transaction Report

Form 4
Period: 2004-01-12
Transactions
  • Sale

    Warrant representing the right to buy Common Stock

    2004-01-12$0.07/sh759,493$53,1651,265,822 total(indirect: The Warrants are held by Defiante Farmaceutica L.d.A.)
    Exercise: $1.70From: 2002-03-15Exp: 2006-03-15Common Stock, no par value per share (759,493 underlying)
  • Purchase

    Common Stock, no par value per share

    2004-01-12$0.64/sh+759,493$489,113759,493 total(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
Holdings
  • Common Stock, no par value per share

    (indirect: Shares underlying the Warrants held by Defiante Farmaceutica L.d.A.)
    1,265,822
  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza.)
    1,756,782
  • Common Stock, no par value per share

    8,643,397
  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza.)
    1,756,781
Footnotes (1)
  • [F1]Sigma-Tau Finanziaria S.p.A. owns 100% of the capital stock of Sigma-Tau International S.A. (f/k/a Sigma-Tau Finance Holding S.A.) and 58% of the capital stock of Defiante Farmaceutica L.d.A. Sigma-Tau International S.A. owns 42% of the capital stock of Defiante Farmaceutica L.d.A. Claudio Cavazza owns, directly and indirectly, 60% of Sigma-Tau Finanziaria S.p.A. and Paolo Cavazza owns, directly and indirectly, 40% of Sigma-Tau Finanziaria S.p.A. Paolo Cavazza also owns, directly and indirectly, 100% of Aptafin S.p.A.

Issuer

QUESTCOR PHARMACEUTICALS INC

CIK 0000891288

Entity typeother

Related Parties

1
  • filerCIK 0001163608

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 8:31 PM ET
Size
19.1 KB